FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3158041423> ?p ?o ?g. }

• W3158041423 endingPage "112" @default.
• W3158041423 startingPage "105" @default.
• W3158041423 abstract "Atrial fibrillation (AF), the most frequent arrhythmia of older patients, associates with serious thromboembolic complications and high mortality. Coronavirus disease 2019 (COVID-19) severely affects aged subjects, determining an important prothrombotic status. The aim of this study was to evaluate mortality-related factors in older AF patients with COVID-19.Between March and June 2020, we enrolled ≥60 year-old in-hospital COVID-19 patients (n = 806) in GeroCovid, a multicenter observational study promoted by the Italian Society of Gerontology and Geriatric Medicine.The prevalence of AF was 21.8%. In-hospital mortality was higher in the AF group (36.9 vs. 27.5%, p = 0.015). At admission, 51.7, 10.2, and 38.1% of AF cases were taking, respectively, oral anticoagulants (OACs), antiplatelet agents, and no antithrombotic therapy. During hospitalization, 51% patients switched to low-molecular-weight heparins. AF patients who survived were younger (81 ± 8 vs. 84 ± 7 years; p = 0.002) and had a lower CHA2DS2-VASc score (3.9 ± 1.6 vs. 4.4 ± 1.3; p = 0.02) than those who died. OAC use before (63.1 vs. 32.3%; p < 0.001) and during hospitalization (34.0 vs. 12.7%; p = 0.002) was higher among survivors. At multivariable analysis, lower age, higher self-sufficiency, less severe initial COVID-19 presentation, and the use of vitamin K antagonists (odds ratio [OR] = 0.16, 95% confidence interval [CI]: 0.03-0.84) or direct OACs (OR = 0.22, 95% CI: 0.08-0.56) at admission, or the persistence of OAC during hospitalization (OR = 0.05, 95% CI: 0.01-0.24), were associated with a lower chance of in-hospital death.AF is a prevalent and severe condition in older COVID-19 patients. Advanced age, dependency, and relevant clinical manifestations of disease characterized a worse prognosis. Preadmission and in-hospital anticoagulant therapies were positively associated with survival." @default.
• W3158041423 created "2021-05-10" @default.
• W3158041423 creator A5001620644 @default.
• W3158041423 creator A5013214341 @default.
• W3158041423 creator A5014339181 @default.
• W3158041423 creator A5018993345 @default.
• W3158041423 creator A5036258941 @default.
• W3158041423 creator A5051452578 @default.
• W3158041423 creator A5053318143 @default.
• W3158041423 creator A5068090112 @default.
• W3158041423 creator A5080377110 @default.
• W3158041423 creator A5084431244 @default.
• W3158041423 creator A5087765231 @default.
• W3158041423 creator A5090988550 @default.
• W3158041423 creator A5091292742 @default.
• W3158041423 date "2021-05-07" @default.
• W3158041423 modified "2023-10-03" @default.
• W3158041423 title "COVID-19 and Atrial Fibrillation in Older Patients: Does Oral Anticoagulant Therapy Provide a Survival Benefit?—An Insight from the GeroCovid Registry" @default.
• W3158041423 cites W1923129881 @default.
• W3158041423 cites W2369150255 @default.
• W3158041423 cites W2748878894 @default.
• W3158041423 cites W2762010780 @default.
• W3158041423 cites W2794587197 @default.
• W3158041423 cites W3017326650 @default.
• W3158041423 cites W3021828816 @default.
• W3158041423 cites W3025099648 @default.
• W3158041423 cites W3029761916 @default.
• W3158041423 cites W3037553050 @default.
• W3158041423 cites W3043037455 @default.
• W3158041423 cites W3044157866 @default.
• W3158041423 cites W3046635799 @default.
• W3158041423 cites W3081515108 @default.
• W3158041423 cites W3082188176 @default.
• W3158041423 cites W3088234337 @default.
• W3158041423 cites W3089519570 @default.
• W3158041423 cites W3092153701 @default.
• W3158041423 cites W3094039314 @default.
• W3158041423 cites W3096205633 @default.
• W3158041423 cites W3102765560 @default.
• W3158041423 cites W3105113928 @default.
• W3158041423 cites W3107284527 @default.
• W3158041423 cites W3108315781 @default.
• W3158041423 cites W3124061150 @default.
• W3158041423 cites W3126866677 @default.
• W3158041423 cites W3128554484 @default.
• W3158041423 cites W3145827038 @default.
• W3158041423 cites W4256049924 @default.
• W3158041423 doi "https://doi.org/10.1055/a-1503-3875" @default.
• W3158041423 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33962480" @default.
• W3158041423 hasPublicationYear "2021" @default.
• W3158041423 type Work @default.
• W3158041423 sameAs 3158041423 @default.
• W3158041423 citedByCount "20" @default.
• W3158041423 countsByYear W31580414232021 @default.
• W3158041423 countsByYear W31580414232022 @default.
• W3158041423 countsByYear W31580414232023 @default.
• W3158041423 crossrefType "journal-article" @default.
• W3158041423 hasAuthorship W3158041423A5001620644 @default.
• W3158041423 hasAuthorship W3158041423A5013214341 @default.
• W3158041423 hasAuthorship W3158041423A5014339181 @default.
• W3158041423 hasAuthorship W3158041423A5018993345 @default.
• W3158041423 hasAuthorship W3158041423A5036258941 @default.
• W3158041423 hasAuthorship W3158041423A5051452578 @default.
• W3158041423 hasAuthorship W3158041423A5053318143 @default.
• W3158041423 hasAuthorship W3158041423A5068090112 @default.
• W3158041423 hasAuthorship W3158041423A5080377110 @default.
• W3158041423 hasAuthorship W3158041423A5084431244 @default.
• W3158041423 hasAuthorship W3158041423A5087765231 @default.
• W3158041423 hasAuthorship W3158041423A5090988550 @default.
• W3158041423 hasAuthorship W3158041423A5091292742 @default.
• W3158041423 hasBestOaLocation W31580414231 @default.
• W3158041423 hasConcept C126322002 @default.
• W3158041423 hasConcept C156957248 @default.
• W3158041423 hasConcept C187212893 @default.
• W3158041423 hasConcept C2776301958 @default.
• W3158041423 hasConcept C2776704044 @default.
• W3158041423 hasConcept C2777015399 @default.
• W3158041423 hasConcept C2777914695 @default.
• W3158041423 hasConcept C2779161974 @default.
• W3158041423 hasConcept C44249647 @default.
• W3158041423 hasConcept C71924100 @default.
• W3158041423 hasConceptScore W3158041423C126322002 @default.
• W3158041423 hasConceptScore W3158041423C156957248 @default.
• W3158041423 hasConceptScore W3158041423C187212893 @default.
• W3158041423 hasConceptScore W3158041423C2776301958 @default.
• W3158041423 hasConceptScore W3158041423C2776704044 @default.
• W3158041423 hasConceptScore W3158041423C2777015399 @default.
• W3158041423 hasConceptScore W3158041423C2777914695 @default.
• W3158041423 hasConceptScore W3158041423C2779161974 @default.
• W3158041423 hasConceptScore W3158041423C44249647 @default.
• W3158041423 hasConceptScore W3158041423C71924100 @default.
• W3158041423 hasIssue "01" @default.
• W3158041423 hasLocation W31580414231 @default.
• W3158041423 hasLocation W31580414232 @default.
• W3158041423 hasOpenAccess W3158041423 @default.
• W3158041423 hasPrimaryLocation W31580414231 @default.
• W3158041423 hasRelatedWork W1992661224 @default.
• W3158041423 hasRelatedWork W2098931901 @default.

• next